Daunorubicin, cytarabine and 2-CdA (DAC-7) for remission induction in "de novo" adult acute myeloid leukaemia patients. Evaluation of safety, tolerance and antileukemic activity

Acta Haematologica Polonica

Volumn 33, Issue 2, 2002, Pages 239-247

  Hołowiecki, Jerzy ^a   Robak, Tadeusz ^a   Kyrcz Krzemień, Sławomira ^a   Grosicki, Sebastian ^a   Wrzesień Kuś, Agata ^a   Hellmann, Andrzej ^a   Skotnicki, Aleksander ^a   Jȩdrzejczak, Wiesław ^a   Konopka, Lech ^a   Zdziarska, Barbara ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

2 CdA; Acute myeloid leukemia; Cytarabine; Daunorubicin; Efficacy; Induction; Toxicity

Indexed keywords

CLADRIBINE; CYTARABINE; DAUNORUBICIN; FLUDARABINE; PURINE DERIVATIVE; RIBONUCLEOTIDE REDUCTASE;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGRANULOCYTOSIS; ANTINEOPLASTIC ACTIVITY; ARTICLE; CLINICAL ARTICLE; DRUG EFFICACY; DRUG POTENTIATION; DRUG SAFETY; DRUG TOLERANCE; FEMALE; HEART FAILURE; HUMAN; INFECTION; KIDNEY FAILURE; LEUKEMIA REMISSION; LIVER FAILURE; MALE; MYELOBLAST; PANCYTOPENIA; THROMBOCYTOPENIA; TREATMENT OUTCOME;

EID: 0036318347     PISSN: 00015814     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Modulation of ara-CTP levels by fludarabine and hydroxyurea in leukemic cells
2. 2-Chlorodeoxyadenosine (2-CdA) potent chemotherapeutic and immunosuppresive nucleoside
3. Deoxycitidine kinase - Mediated toxicity of deoxyadenosine analogs toward malignant human lymphoblasts in vitro and toward murine L1210 leukemia in vivo
4. Treatment of hairy cell leukemia with 2-chlorodeoxyadenosine (2-CdA)
5. Fludarabine and arabinosylcytosine therapy of refractory and relapsed acute myelogenous leukemia
6. Cell cycle-specyfic metabolism of arabinosyl nucleosides in K 562 human leukemia cells
7. Imbalance of deoxyribonucleoside triphosphates, DNA double-strand breaks and cell death cause by 2-chlorodeoxyadenosine in mouse FM3A cells
8. A systemic overview of chemotherapy effects in acute myeloid leukaemia
9. Wstȩpne wyniki leczenia indukuja̧cego remisjȩ i reindukuja̧cego z użyciem 2-CdA w ostrej bialaczce szpikowej (MLA)
10. Interakcje 2-chlorodeoksyadenozyny i gemcytabiny (2″ 2′-difluorodeoksycytydyny) u myszy z przeszczepialnymi bialaczkami L1210 i P388 oraz w hodowlach prawidlowych i bialaczkowych komȯrek krwiotwórczych in vitro
11. Lasting remissions in hairy cell leukemia induced by a single infusion of 2-chlorodeoxyadenosine N
12. 2-chlorodeoksyadenozyna (2-CdA) - Nowy lek przeciwnowotworowy i immunosupresyjny
13. Combination regimen of cladribine (2-chlorodeoxyadenosine), cytarabine and G-CSF (CLAG) as induction therapy for patients with relapsed of refractory myeloid leukemia
14. Complete hematologic remissions induced by 2-chlorodeioxyadenosine in children with newly diagnosed acute myeloid leukemia
15. 2-chlorodeoxyadenosine produces a high rate of complete hematologic remission in relapsed acute myeloid leukemia
16. Mechanism of deoxyadenosine and 2-chlorodeoxyadenosine toxicity to nondividing human lymphocytes
17. A single cycle of 2-chlorodeoxyadenosine results in complete remission in the majority of patients with hairy cell leukemia
18. Therapeutic and neurotoxic effects of 2-chlorodeoxyadenosine in adults with acute myeloid leukemia
19. 2-Chlorodeoxyadenosine with or without daunorubicin in relapsed or refractory acute myeloid leukemia